We are live on ! Find out more
NXTC icon

NextCure
NXTC

52 hedge funds and large institutions have $34.3M invested in NextCure in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more call options, than puts

Call options by funds: $1.11M | Put options by funds: $687K

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

2% more funds holding

Funds holding: 51 → 52 (+1)

0.24% more ownership

Funds ownership: 4.34% → 4.58% (+0.24%)

13% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 15

38% less capital invested

Capital invested by funds: $55.2M → $34.3M (-$20.9M)

Holders
52
Holders Change
+1
Holders Change %
+1.96%
% of All Funds
0.9%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
13
Reduced
15
Closed
4
Calls
$1.11M
Puts
$687K
Net Calls
+$425K
Net Calls Change
-$2.25M

Top Buyers

Rank Fund Capital Flow
1
KPF
K2 Principal Fund
Ontario, Canada
+$3.37M
2
Millennium Management
Millennium Management
New York
+$429K
3
Citadel Advisors
Citadel Advisors
Florida
+$343K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$225K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$211K

Top Sellers

Rank Fund Capital Flow
1
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$511K
2
IC
Ikarian Capital
Texas
-$336K
3
BCM
Bridgeway Capital Management
Texas
-$297K
4
Renaissance Technologies
Renaissance Technologies
New York
-$262K
5
Bank of America
Bank of America
North Carolina
-$153K
Name Holding Trade Value Shares
Change 		Change in
Stake
SI
1
Sofinnova Investments
California
$7.35M – – –
KPF
2
K2 Principal Fund
Ontario, Canada
$4.19M +$3.37M +66,082 +101%
BlackRock
3
BlackRock
New York
$3.43M -$75K -1,472 -1%
Millennium Management
4
Millennium Management
New York
$3.34M +$429K +8,426 +9%
Vanguard Group
5
Vanguard Group
Pennsylvania
$2.5M -$111K -2,184 -3%
LFCM
6
Long Focus Capital Management
Puerto Rico
$1.53M – – –
Federated Hermes
7
Federated Hermes
Pennsylvania
$1.45M +$306 +6 +0%
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
$1.32M +$225K +4,411 +12%
Citadel Advisors
9
Citadel Advisors
Florida
$1.3M +$343K +6,727 +21%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$926K – – –
Goldman Sachs
11
Goldman Sachs
New York
$925K -$11.4K -223 -0.8%
Acadian Asset Management
12
Acadian Asset Management
Massachusetts
$825K -$24.6K -482 -2%
Renaissance Technologies
13
Renaissance Technologies
New York
$633K -$262K -5,145 -21%
DCM
14
DAFNA Capital Management
California
$516K – – –
Geode Capital Management
15
Geode Capital Management
Massachusetts
$464K -$9.28K -182 -1%
Two Sigma Advisers
16
Two Sigma Advisers
New York
$421K +$211K +4,134 +48%
Macquarie Group
17
Macquarie Group
Australia
$413K – – –
SCM
18
Sio Capital Management
New York
$358K – – –
Connor, Clark & Lunn Investment Management (CC&L)
19
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$264K +$127K +2,493 +45%
Barclays
20
Barclays
United Kingdom
$187K – – –
Two Sigma Investments
21
Two Sigma Investments
New York
$173K +$194K +3,811 +264%
State Street
22
State Street
Massachusetts
$157K – – –
BCM
23
Bridgeway Capital Management
Texas
$150K -$297K -5,834 -56%
Nomura Holdings
24
Nomura Holdings
Japan
$148K – – –
Norges Bank
25
Norges Bank
Norway
$143K – – –
1
2 3

NXTC Hedge Fund Activity: Q3 2022 in Review

52 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in NextCure (NXTC) for Q3 2022, worth a combined $34.3M — down 38% from $55.2M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new NXTC positions and 4 closed out — a net gain of 1 holder — while 13 added to existing stakes and 15 trimmed.

The largest buyer was K2 Principal Fund, adding an estimated $3.37M. The largest seller was Assenagon Asset Management, exiting entirely with an estimated $511K sold.

  • 52 institutional investors held NextCure (NXTC) as of Q3 2022, up from 51 in Q2 2022.
  • Funds reported $34.3M of NextCure stock for Q3 2022, down 38% quarter-over-quarter.
  • 5 funds opened new NextCure positions in Q3 2022 and 4 closed out, a net change of +1 holder.
  • The largest NextCure buyer in Q3 2022 was K2 Principal Fund, an estimated $3.37M added.
  • The largest NextCure seller in Q3 2022 was Assenagon Asset Management, an estimated $511K sold.

Based on aggregated 13F filings for Q3 2022.